# US 2020/0347413 A1 · Partially buffered free acid and/or ketone blend for rapid onset ketosis and metabolic therapy

> Agents: this data is available as JSON from the patentgrep API and MCP server — see https://patentgrep.com/llms.txt

- Number: US 2020/0347413 A1
- Document ID: US20200347413A1
- Status: Published application
- Kind: A1
- Application number: 16/947,036
- Filed: 2020-07-15
- Published: 2020-11-05
- Earliest claimed: 2016-08-30
- Assignees: KetoneAid Inc.
- Inventors: Frank Borges LLOSA; Stephen ZARPAS
- Web page: https://patentgrep.com/patent/US20200347413A1

## CPC

- C12P 7/26: Ketones
- A23L 33/10: using additives (addition of substantially indigestible substances A23L33/21)
- A23L 33/16: Inorganic salts, minerals or trace elements
- C12C 5/026: {Beer flavouring preparations}
- C12C 12/04: Beer with low alcohol content (methods for reducing the alcohol content after fermentation C12H3/00)
- C12P 7/52: Propionic acid; Butyric acids
- A23L 5/00: Preparation or treatment of foods or foodstuffs, in general; Food or foodstuffs obtained thereby; Materials therefor
- C12C 11/11: Post fermentation treatments, e.g. carbonation, or concentration (methods for reducing the alcohol content after fermentation C12H3/00; methods for increasing the alcohol content after fermentation C12H6/00)
- C12P: FERMENTATION OR ENZYME-USING PROCESSES TO SYNTHESISE A DESIRED CHEMICAL COMPOUND OR COMPOSITION OR TO SEPARATE OPTICAL ISOMERS FROM A RACEMIC MIXTURE {(brewing of beer C12C; producing vinegar C12J; producing specific peptides or proteins C07K; producing enzymes C12N9/00; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification C12N15/00; measuring or testing processes involving enzymes or microorganisms C12Q; measuring or testing processes involving nucleic acid amplification reactions C12Q1/6844; fermentation processes to form a food composition, A21 or A23; compounds in general, see the relevant compound class, e.g. C01, C07)}
- A23L: FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES, NOT OTHERWISE PROVIDED FOR; PREPARATION OR TREATMENT THEREOF (preservation thereof A23B)
- C12C: BEER; PREPARATION OF BEER BY FERMENTATION (ageing or ripening by storing C12H1/22; methods for reducing the alcohol content after fermentation C12H3/00; methods for increasing the alcohol content after fermentation C12H6/00; venting devices for casks, barrels or the like C12L9/00); PREPARATION OF MALT FOR MAKING BEER; PREPARATION OF HOPS FOR MAKING BEER

## Abstract

A foodstuff can include a free acid β-hydroxybutyrate, and a base. The β-hydroxybutyrate, and base, are present at a less than 1:1 molar equivalence. Ketone Ester may also be incorporated as a component of the foodstuff.

## Claims

### Claim 1

A foodstuff comprising:
free acid β-hydroxybutyrate; and
a base
wherein the base is less than a 1:1 molar equivalent with respect to the free acid β-hydroxybutyrate.

### Claim 2 (depends on 1)

The foodstuff of claim 1, having a molar ratio 10 parts free acid β-hydroxybutyrate and between 2-8 parts of the base.

### Claim 3 (depends on 1)

The foodstuff of claim 1, wherein the free acid β-hydroxybutyrate is replaced with an enantiomerically enriched (D)β-hydroxybutyrate.

### Claim 4 (depends on 1)

The foodstuff of claim 1, wherein the free acid β-hydroxybutyrate is replaced with an enantiomerically pure (D)-β-hydroxybutyrate.

### Claim 5 (depends on 1)

The foodstuff of claim 1, further comprising a Ketone Ester.

### Claim 6 (depends on 1)

The foodstuff of claim 1, wherein the foodstuff is encapsulated with an enteric coating.

### Claim 7 (depends on 1)

The foodstuff of claim 1, wherein the foodstuff is administered with a stomach acid inhibitor.

### Claim 8 (depends on 1)

The foodstuff of claim 1, wherein the base is comprised of at least one of the following; Na+, K+, and Ca+.

### Claim 9

A method of consuming a foodstuff to elevate ketone levels in the body of a user comprising the steps of:
consuming a free acid β-hydroxybutyrate and a base at an effective dose,
wherein the amount of base is less than a 1:1 molar equivalent with respect to the free acid β-hydroxybutyrate.

### Claim 10 (depends on 9)

The method of claim 9, wherein a Ketone Ester is consumed.

### Claim 11 (depends on 9)

The method of claim 9, wherein the effective dose is defined as up to 2 g/kg of body weight per day, wherein the effective dose treats erectile dysfunction.

### Claim 12 (depends on 9)

The method of claim 9, wherein the effective dose is defined as up to 2 g/kg of body weight per day, wherein the effective dose treats hair loss.

### Claim 13 (depends on 9)

The method of claim 9, wherein the effective dose is defined as up to 2 g/kg of body weight per day, wherein the effective dose improves visual acuity.

### Claim 14 (depends on 9)

The method of claim 9, wherein the effective dose is defined as up to 2 g/kg of body weight per day, wherein the effective dose treats amyotrophic lateral sclerosis.

### Claim 15 (depends on 9)

The method of claim 9, wherein the effective dose is defined as up to 2 g/kg of body weight per day, wherein the effective dose treats a brain injury.

### Claim 16 (depends on 9)

The method of claim 9, wherein the effective dose is defined as up to 2 g/kg of body weight per day, wherein the effective dose enhances athletic performance.

### Claim 17 (depends on 16)

The method of claim 16, wherein 0.5 to 2 times the amount of carbohydrates with respect to the effective dose are consumed by the user.

### Claim 18 (depends on 17)

The method of claim 17, wherein the carbohydrates are administered prior to the ketones.

### Claim 19 (depends on 9)

The method of claim 9, wherein the effective dose is defined as up to 2 g/kg of body weight per day, wherein the effective dose prevents hyperglycemia.

### Claim 20 (depends on 9)

The method of claim 9, wherein the effective dose is defined as up to 2 g/kg of body weight per day, wherein the effective dose improves myocardial blood flow and efficiency.
